Pheochromocytomas and paragangliomas are rare tumors, but their investigation and management are complex and expensive, both in terms of time and resources. A novel prospective study systematically compared different imaging techniques, and the results provide clinicians with valuable help in deciding the appropriate imaging strategy for patients with pheochromocytomas or paragangliomas.
References
Neumann, H. P. et al. Germ-line mutations in nonsyndromic pheochromocytoma. N. Engl. J. Med. 346, 1459–1466 (2002).
Bauters, C. et al. Hereditary phaeochromocytomas and paragangliomas: a study of five susceptibility genes. J. Med. Genet. 40, e75 (2003).
Amar, L. et al. Genetic testing in pheochromocytoma or functional paraganglioma. J. Clin. Oncol. 23, 8812–8882 (2005).
O'Riordain, D. S., Young, W. F. Jr, Grant, C. S., Carney, J. A. & van Heerden, J. A. Clinical spectrum and outcome of functional extraadrenal paraganglioma. World J. Surg. 20, 916–921 (1996).
Timmers, H. J. et al. Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma. J. Clin. Endocrinol. Metab. 94, 4757–4767 (2009).
Brenner, D. J. & Hall, E. J. Computed tomography—an increasing source of radiation exposure. N. Engl. J. Med. 357, 2277–2284 (2007).
Timmers, H. J. et al. Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma. J. Clin. Oncol. 25, 2262–2269 (2007).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Chew, S. Imaging of pheochromocytomas and paragangliomas. Nat Rev Endocrinol 6, 193–194 (2010). https://doi.org/10.1038/nrendo.2010.22
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2010.22
- Springer Nature Limited